7.32
price up icon0.97%   0.07
after-market Dopo l'orario di chiusura: 7.42 0.10 +1.37%
loading
Precedente Chiudi:
$7.25
Aprire:
$7.28
Volume 24 ore:
5.72M
Relative Volume:
1.35
Capitalizzazione di mercato:
$1.54B
Reddito:
$557.51M
Utile/perdita netta:
$-35.71M
Rapporto P/E:
-40.67
EPS:
-0.18
Flusso di cassa netto:
$15.50M
1 W Prestazione:
+1.67%
1M Prestazione:
-3.56%
6M Prestazione:
-17.29%
1 anno Prestazione:
-8.61%
Intervallo 1D:
Value
$7.18
$7.47
Intervallo di 1 settimana:
Value
$7.17
$7.47
Portata 52W:
Value
$6.00
$11.31

Biocryst Pharmaceuticals Inc Stock (BCRX) Company Profile

Name
Nome
Biocryst Pharmaceuticals Inc
Name
Telefono
919-859-1302
Name
Indirizzo
4505 EMPEROR BOULEVARD, DURHAM, NC
Name
Dipendente
580
Name
Cinguettio
@biocrystpharma
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
BCRX's Discussions on Twitter

Confronta BCRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
BCRX
Biocryst Pharmaceuticals Inc
7.32 1.53B 557.51M -35.71M 15.50M -0.18
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Biocryst Pharmaceuticals Inc Stock (BCRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-15 Ripresa TD Cowen Buy
2025-10-01 Downgrade Evercore ISI Outperform → In-line
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2025-02-25 Iniziato Wedbush Outperform
2023-11-20 Ripresa JP Morgan Overweight
2023-09-18 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-08-04 Aggiornamento Jefferies Hold → Buy
2023-07-13 Aggiornamento BofA Securities Neutral → Buy
2023-02-22 Aggiornamento Needham Hold → Buy
2022-11-02 Aggiornamento Evercore ISI In-line → Outperform
2022-08-05 Downgrade Evercore ISI Outperform → In-line
2022-08-05 Downgrade Oppenheimer Outperform → Perform
2022-04-18 Downgrade Barclays Overweight → Equal Weight
2022-04-11 Downgrade BofA Securities Buy → Neutral
2021-12-10 Iniziato Oppenheimer Outperform
2021-08-06 Downgrade Jefferies Buy → Hold
2021-08-03 Iniziato Cantor Fitzgerald Overweight
2021-03-01 Iniziato Cowen Outperform
2020-09-29 Ripresa JP Morgan Overweight
2020-06-17 Iniziato BTIG Research Neutral
2020-05-05 Aggiornamento Barclays Equal Weight → Overweight
2019-11-15 Aggiornamento BofA/Merrill Neutral → Buy
2019-05-24 Downgrade RBC Capital Mkts Outperform → Sector Perform
2018-11-16 Ripresa Piper Jaffray Overweight
2018-08-08 Ripresa JP Morgan Overweight
2018-07-17 Aggiornamento BofA/Merrill Underperform → Neutral
2018-06-22 Iniziato Seaport Global Securities Neutral
2018-01-02 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2017-12-20 Iniziato Barclays Equal Weight
2017-09-15 Iniziato RBC Capital Mkts Sector Perform
2017-09-06 Aggiornamento JP Morgan Neutral → Overweight
2017-09-06 Aggiornamento Jefferies Hold → Buy
2017-02-16 Iniziato Ladenburg Thalmann Buy
2016-08-12 Aggiornamento Piper Jaffray Neutral → Overweight
2016-08-04 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 Reiterato FBR Capital Outperform
2016-02-09 Downgrade JP Morgan Overweight → Neutral
2016-02-09 Downgrade Needham Buy → Hold
Mostra tutto

Biocryst Pharmaceuticals Inc Borsa (BCRX) Ultime notizie

pulisher
06:48 AM

Will BioCryst Pharmaceuticals Inc. stock maintain growth storyGlobal Markets & Reliable Intraday Trade Plans - newser.com

06:48 AM
pulisher
06:12 AM

What technical models suggest about BioCryst Pharmaceuticals Inc.’s comebackEarnings Miss & Daily Profit Focused Stock Screening - newser.com

06:12 AM
pulisher
05:13 AM

Is BioCryst Pharmaceuticals Inc. stock bottoming out2025 Momentum Check & Smart Swing Trading Techniques - newser.com

05:13 AM
pulisher
04:40 AM

Is BioCryst Pharmaceuticals Inc. stock ready for a breakoutEarnings Risk Summary & Real-Time Price Movement Reports - newser.com

04:40 AM
pulisher
12:53 PM

Why retail investors pile into BioCryst Pharmaceuticals Inc. stock2025 Short Interest & Verified Technical Signals - newser.com

12:53 PM
pulisher
Oct 30, 2025

Will BioCryst Pharmaceuticals Inc. stock attract ESG investorsMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Why BioCryst Pharmaceuticals Inc. stock could benefit from AI revolutionWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

# BioCryst’s SWOT analysis: stock positioned for growth amid HAE market expansion - Investing.com

Oct 30, 2025
pulisher
Oct 29, 2025

BioCryst Pharmaceuticals (BCRX) Price Target Increased by 19.59% to 21.51 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

BioCryst Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Why BioCryst Shares Plunged - AOL.com

Oct 28, 2025
pulisher
Oct 28, 2025

Aug Shorts: Why hedge funds are buying BioCryst Pharmaceuticals Inc. stockTrade Entry Report & Weekly Stock Performance Updates - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

When is the best time to exit BioCryst Pharmaceuticals Inc.July 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy? - sharewise.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will BioCryst Pharmaceuticals Inc. stock outperform international peersPortfolio Update Report & AI Optimized Trading Strategy Guides - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

BioCryst Pharmaceuticals (BCRX) Projected to Post Earnings on Monday - MarketBeat

Oct 27, 2025

Biocryst Pharmaceuticals Inc Azioni (BCRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Biocryst Pharmaceuticals Inc Azioni (BCRX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
HEGGIE THERESA
Director
Aug 13 '25
Sale
8.51
70,000
595,868
65,352
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Capitalizzazione:     |  Volume (24 ore):